Lawsuits for Patients with Gadolinium Deposition Disease

September 26, 2018

Comments |

At A Glance

This Alert Affects:
Anyone who has been diagnosed with or developed symptoms of gadolinium deposition disease (GDD) following multiple MRIs.
What’s Gadolinium Deposition Disease?
GDD refers to the group of persistent symptoms that develop in MRI patients with normal kidney function within two months of being injected with a gadolinium-based contrast agent. These symptoms include “brain fog;” persistent headaches; thickened tendon and ligaments; and tingling, burning and numbness.
What’s Going On?
Patients are suing the manufacturers of gadolinium-based contrast agents claiming that the dyes made them sick and that they’re owed money for their suffering and medical costs.
How Can a Lawsuit Help?
A successful case could provide patients with compensation for their medical expenses, physical and mental suffering, and wages lost from being unable to work.
Contact Us